Maresyl 0,5 Mg/Ml

Xylometazoline Hydrochloride, the active ingredient in Maresyl 0,5 Mg/Ml, is an imidazoline nasal decongestant presented as a 0.5 mg/mL nasal solution for nasal use. It relieves nasal congestion associated with the common cold, sinusitis, and allergic rhinitis in adults and children.

GNH USA supplies Maresyl 0,5 Mg/Ml as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Xylometazoline Hydrochloride is an imidazoline nasal decongestant that reduces swelling of the nasal mucosa.

- Common cold: alleviates nasal blockage by decreasing mucosal edema. - Sinusitis: improves airflow and eases sinus pressure. - Allergic rhinitis: diminishes congestion caused by allergic inflammation.

Xylometazoline Hydrochloride may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation: mild burning or stinging sensation. - Sneezing: transient increase in sneezing episodes. - Dryness of nasal mucosa: feeling of dryness or crusting. - Headache: mild headache.

Serious or Rare Side Effects: - Rebound congestion: worsening nasal blockage after prolonged use. - Hypertension: elevated blood pressure in susceptible individuals. - Cardiac arrhythmia: irregular heartbeat in rare cases.

When using Maresyl 0,5 Mg/Ml, certain precautions should be observed to minimize risks.

- Age limitation: avoid use in children under 6 years unless directed by a healthcare professional. - Duration of use: limit treatment to no more than 3–5 consecutive days to prevent rebound congestion. - Pre‑existing conditions: use cautiously in patients with hypertension, cardiovascular disease, or thyroid disorders. - Pregnancy and lactation: consult a physician before use as safety data are limited. - Drug interactions: inform the prescriber of any concurrent nasal or systemic decongestants. - Store at ambient temperature: keep below 25 °C, protect from moisture and direct sunlight, and retain in original container.

Xylometazoline Hydrochloride can interact with other medications, primarily affecting cardiovascular and adrenergic pathways.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may potentiate hypertensive effects. - Systemic sympathomimetics (e.g., pseudoephedrine): increased risk of hypertension and tachycardia.

Moderate Interactions (Monitor Closely): - Beta‑blockers: possible attenuation of decongestant effect and altered blood pressure response. - Antihypertensive agents: may reduce efficacy of blood pressure control. - Tricyclic antidepressants: potential additive cardiovascular stimulation.